Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Envoy Medical Inc (COCH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Notes

Alerts

Watch

Help

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study Newsfile - Thu Dec 19, 8:14AM CST

Initial patient enrollment anticipated during first quarter of 2025White Bear Lake, Minnesota--(Newsfile Corp. - December 19, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Envoy Medical, Inc. Announces Issuance of Four New Patents for Innovative Cochlear Implant Technologies Quiver Quantitative, Inc. - Mon Dec 16, 6:12PM CST

Envoy Medical announces four new patents related to cochlear implants and hearing aids, enhancing innovative hearing solutions.Quiver AI SummaryEnvoy Medical, Inc. announced the issuance of four new patents...

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss GlobeNewswire - Mon Dec 16, 8:00AM CST

Envoy Medical Reports Q3 2024 Financial Results and Progress on Fully Implanted Hearing Devices Quiver Quantitative, Inc. - Thu Nov 14, 5:52PM CST

Envoy Medical reports Q3 2024 results, highlighting FDA approval for Acclaim CI trial and reimbursement progress for Esteem device.Quiver AI SummaryEnvoy Medical, Inc. reported its third-quarter financial...

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events GlobeNewswire - Thu Nov 14, 7:38AM CST

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication GlobeNewswire - Tue Nov 12, 8:25AM CST

Building Permits, Vehicle Sales Due Next Week Baystreet - Fri Nov 8, 2:34PM CST

Monday U.S. Featured Earnings Monday.Com Ltd (NASDAQ: MNDY) (Q3) EPS of four cents, compared ...